These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26740046)

  • 1. The influence of cardiovascular autonomic neuropathy on mortality in type 1 diabetic patients; 10-year follow-up.
    Lacigova S; Brozova J; Cechurova D; Tomesova J; Krcma M; Rusavy Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):111-7. PubMed ID: 26740046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthostatic hypotension in diabetic patients-10-year follow-up study.
    Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
    J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
    Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Witte DR; Jørgensen ME
    Diabetologia; 2019 Apr; 62(4):633-643. PubMed ID: 30649599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Astrup AS; Tarnow L; Rossing P; Hansen BV; Hilsted J; Parving HH
    Diabetes Care; 2006 Feb; 29(2):334-9. PubMed ID: 16443883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could we predict asymptomatic cardiovascular autonomic neuropathy in type 1 diabetic patients attending out-patients clinics?
    Lacigová S; Safránek P; Cechurová D; Krcma M; Vísek J; Jankovec Z; Zourek M; Haladová I; Rusavý Z
    Wien Klin Wochenschr; 2007; 119(9-10):303-8. PubMed ID: 17571235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease.
    Tikkanen-Dolenc H; Wadén J; Forsblom C; Harjutsalo V; Thorn LM; Saraheimo M; Elonen N; Tikkanen HO; Groop PH;
    Diabetes Care; 2017 Dec; 40(12):1727-1732. PubMed ID: 29038314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Jorsal A; Tarnow L; Flyvbjerg A; Parving HH; Rossing P; Rasmussen LM
    Diabetologia; 2008 Nov; 51(11):2100-7. PubMed ID: 18719882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes.
    O'Brien IA; McFadden JP; Corrall RJ
    Q J Med; 1991 Jun; 79(290):495-502. PubMed ID: 1946930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes.
    Pavy-Le Traon A; Fontaine S; Tap G; Guidolin B; Senard JM; Hanaire H
    Clin Auton Res; 2010 Jun; 20(3):153-60. PubMed ID: 20354891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Aug; 29(8):990-4. PubMed ID: 22414297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
    J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.
    Branch M; German C; Bertoni A; Yeboah J
    J Diabetes Complications; 2019 Jul; 33(7):468-472. PubMed ID: 31088728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intensive treatment of diabetes of the risk of death or renal failure in NIDDM and IDDM.
    Hellman R; Regan J; Rosen H
    Diabetes Care; 1997 Mar; 20(3):258-64. PubMed ID: 9051368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.